NCT04464200 19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04461483 A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose and Multiple Doses With Titration of TAK-935 in Healthy Japanese Participants Status COMPLETED Phase PHASE1
NCT04449484 Multiple Ascending Dose Study of MEDI1341 in Patients With Parkinson's Disease Status COMPLETED Phase PHASE1
NCT04446117 Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04445129 Wake and Sleep State Transitions on a Portable Electroencephalogram (EEG) Device in Narcolepsy Type 1 (NT1) and Healthy Participants Status COMPLETED Phase N/A
NCT04441255 A Study to Evaluate the Effect of High-Fat Meal on TAK-788 Pharmacokinetics (PK) in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT04420884 A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT04419649 A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Status RECRUITING Phase PHASE2
NCT04405778 A Study of TAK-102 in Adult With Previously-Treated Solid Tumors Status TERMINATED Phase PHASE1
NCT04381650 A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT04374305 Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2) Status RECRUITING Phase PHASE2
NCT04362735 Efficacy of Vedolizumab in Crohn's Disease Patients Naive to Biological Therapy Status UNKNOWN Phase N/A
NCT04349449 ENTYVIO in Bio-naive Patients With Moderate/Severe Crohn's Disease (CD) in Daily Practice Status WITHDRAWN Phase N/A
NCT04318938 Advancing Brigatinib Properties in ALK+ NSCLC Patients by Deep Phenotyping Status COMPLETED Phase PHASE2
NCT04313244 Immunogenicity and Safety of Dengue Tetravalent Vaccine (TDV) and Recombinant 9-valent Human Papillomavirus Vaccine (9vHPV) in Participants Aged ≥9 to <15 Years Status COMPLETED Phase PHASE3
NCT04311541 A Study of Dexlansoprazole Modified Release (MR) in Gastroesophageal Reflux Disease (GERD) Participants in the Russian Federation Status WITHDRAWN Phase N/A
NCT04301011 Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors Status TERMINATED Phase PHASE1